PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort
Yanfei Wang, Chenxi Xiong, Weifeng Yu, Minghao Zhou, Tyler A. Shugg, Fang-Chi Hsu, Michael T. Eadon, Jing Su, Qianqian Song
doi: https://doi.org/10.1101/2024.06.20.24309197
Yanfei Wang
1Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Florida, USA
Chenxi Xiong
2Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indiana, USA
3Department of Computer and Information Technology, Purdue University, Indiana, USA
Weifeng Yu
4Department of Computer Science, University of Virginia, Virginia, USA
Minghao Zhou
1Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Florida, USA
Tyler A. Shugg
5Division of Clinical Pharmacology, Indiana University School of Medicine, Indiana, USA
Fang-Chi Hsu
6Biostatistics and Data Science, Wake Forest School of Medicine, North Carolina, USA
Michael T. Eadon
7Department of Medicine, Indiana University School of Medicine, Indiana, USA
Jing Su
2Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indiana, USA
Qianqian Song
1Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Florida, USA
Data Availability
All data produced are available online at All of US.
Posted June 20, 2024.
PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort
Yanfei Wang, Chenxi Xiong, Weifeng Yu, Minghao Zhou, Tyler A. Shugg, Fang-Chi Hsu, Michael T. Eadon, Jing Su, Qianqian Song
medRxiv 2024.06.20.24309197; doi: https://doi.org/10.1101/2024.06.20.24309197
PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort
Yanfei Wang, Chenxi Xiong, Weifeng Yu, Minghao Zhou, Tyler A. Shugg, Fang-Chi Hsu, Michael T. Eadon, Jing Su, Qianqian Song
medRxiv 2024.06.20.24309197; doi: https://doi.org/10.1101/2024.06.20.24309197
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (205)
- Cardiovascular Medicine (2966)
- Dermatology (251)
- Emergency Medicine (445)
- Epidemiology (12796)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4616)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2940)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (931)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4396)
- Nursing (238)
- Nutrition (646)
- Oncology (2288)
- Ophthalmology (651)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6988)
- Radiology and Imaging (1541)
- Respiratory Medicine (919)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)